Philip R. Schauer MD, FACS, FASMBS
Mary Kay and Terrell Brown / Harris J. Chustz Chair
Professor of Metabolic Surgery
Pennington Biomedical Research Center at Louisiana State University
Dr. Philip Schauer is the Mary Kay and Terrell Brown / Harris J. Chustz endowed Professor of Metabolic Surgery at Pennington Biomedical Research Center of Louisiana State University in Baton Rouge, Louisiana. He is Director of the Bariatric and Metabolic Institute at Pennington Biomedical. He is formerly Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. He is past president of the American Society for Metabolic & Bariatric Surgery (ASMBS). He is former Chair and founder of Obesity Week (2012-present) and Co-Chair of the Diabetes Surgery Summit (2007, 2015, 2019).
Dr. Schauer's clinical interests include obesity, diabetes and metabolic surgery. He has performed more than 8000 operations for severe obesity and diabetes. His research interests include the pathophysiology of obesity and type 2 diabetes, and outcomes of metabolic surgery.
He has authored more than 400 scientific papers, 60 textbook chapters, and 3 textbooks related to obesity, bariatric/metabolic surgery and gastrointestinal surgery with more than 20,000 citations, highest amongst peers. He is principal investigator of the STAMPEDE trail comparing medical and surgical treatment of diabetes published in New England Journal of Medicine (2012, 2014, 2017) with more than 3500 citations and numerous awards from American Heart Association, American College of Cardiology, NIH and Wall Street Journal. He has been principal investigator on 3 NIH funded studies evaluating surgical treatment of diabetes and obesity. He is past chairman of the Bariatric Surgery Section of The Obesity Society (TOS). He has been a member of the editorial board of the International Journal of Obesity, Surgery for Obesity and Related Diseases and Obesity Surgery as well as 3 other scientific journals. He has been an invited speaker for more than 200 international lectures on the subject of metabolic surgery. He is founder of the Minimally Invasive Surgery Symposium (MISS) now in its 20th year. He has trained more than 200 postgraduate surgeons and 100 fellows in advanced laparoscopic and bariatric surgery (3 Presidents of ASMBS). He holds 4 patents for medical devices. He is the recipient of the Cleveland Clinic 2015 Sones Award – highest honor for scientific innovation at the Cleveland Clinic. He is the recipient of the SAGES Pioneer in Surgical Endoscopy Award 2018.
Tony Chetty, MD, FRCP(C) , MSc.
Associate Professor, Dept of Pathology and Molecular Medicine, McMaster University
Medical Director, Bariatric Medical Clinic, St. Joseph's Healthcare, Hamilton
Chair, Bariatric Medical Program Committee,
Ontario Bariatric Network
Dr. Tony Chetty obtained his Medical Degree in South Africa. He completed his Fellowship in Medical Biochemistry and Master's Degree in Health Research Methodology at McMaster University. His research interests have a focus on Clinical Trials, New Pharmacological approaches in Obesity and Type 2 DM Mx. He is currently an Associate Professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Chetty is the Medical Director of the Bariatric Medical Clinic at St. Joseph Healthcare Hamilton. He is also Chair of the Medical Program task force Committee of the Ontario Bariatric Network.
David E. Harris, MD, FRCP(C)
Diplomate of the American Board of Obesity Medicine
Richmond Metabolic and Bariatric Surgery Program
LEAF Weight Management Clinic
Dr. Harris is an Endocrinologist and General Internist trained at the University of British Columbia. He has completed the American Boards in Obesity and Bariatric Medicine. He works as a medical director of the Richmond Metabolic and Bariatric Surgery Program in Richmond, BC, for the past 6 years, and still remotely today.
Recently, his family relocated to Ottawa, and he has joined the LEAF Medical Weight Management Clinic. Dr. Harris enjoys teaching physicians in obesity and bariatrics, and participates in conducting clinical research - mainly studies in the bariatric surgery process, diabetes, and immunology integrated with clinical obesity studies. His future research goals include pharmacological studies of obesity, and also studies of brown and beige adipose tissue.